These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4694912)

  • 1. Prophylactic aspirin?
    Frank MJ; Frank N
    Ann Intern Med; 1973 Mar; 78(3):462. PubMed ID: 4694912
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin in prophylaxis of ischemic heart disease.
    McCormick J
    Br Med J; 1973 Sep; 3(5880):591-2. PubMed ID: 4580220
    [No Abstract]   [Full Text] [Related]  

  • 3. [20,000 kg aspirin and 45 pages British Medical Journal].
    Rosendaal FR; Algra A
    Ned Tijdschr Geneeskd; 1994 May; 138(20):996-1000. PubMed ID: 8196806
    [No Abstract]   [Full Text] [Related]  

  • 4. [The antithrombotic action of oral anticoagulants, acetylsalicylic acid (Aspirin) and dipyridamole (Persantin)].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1984 Oct; 128(43):2047-9. PubMed ID: 6390223
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of serotonin 5HT2 receptor antagonism in the control of coronary artery disease.
    Noble MI; Drake-Holland AJ
    Q J Med; 1994 Jan; 87(1):11-6. PubMed ID: 8140212
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological prevention of coronary thrombosis].
    Spławińska B; Spławiński J
    Pol Tyg Lek; 1987 Jun; 42(26):795-801. PubMed ID: 3313320
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin and emboli.
    Cheng TO
    Lancet; 1981 Oct; 2(8250):809. PubMed ID: 6116933
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of coronary and cerebral thrombosis.
    CRAVEN LL
    Miss Valley Med J; 1956 Sep; 78(5):213-5. PubMed ID: 13358612
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of and risk associated with aspirin therapy in hemodialysis patients with a background of antiplatelet factor 4/heparin complex antibody detection.
    Yang Y; Wang C; Jin L; Chen G; Li C; Qi K; Kong D; Wang Y; Song M; Ma L
    Thromb Res; 2015 Jul; 136(1):61-8. PubMed ID: 25936230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin for the prevention of coronary thrombosis: current facts and perspectives.
    Patrono C
    Eur Heart J; 1986 Jun; 7(6):454-9. PubMed ID: 3525167
    [No Abstract]   [Full Text] [Related]  

  • 11. Does aspirin have a prophylactic vascular effect?
    N Z Med J; 1979 Mar; 89(631):176-7. PubMed ID: 287938
    [No Abstract]   [Full Text] [Related]  

  • 12. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acetylsalicylic acid. The dosage question].
    Stormorken H
    Tidsskr Nor Laegeforen; 1987 Jan; 107(2):183-4. PubMed ID: 3824309
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary prevention of coronary heart disease with aspirin].
    Kübler W
    Z Kardiol; 2004; 93 Suppl 2():II33-6. PubMed ID: 15021994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic aspirin and the elderly population.
    Dalen JE; Goldberg RJ
    Clin Geriatr Med; 1992 Feb; 8(1):119-26. PubMed ID: 1576570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin in the prevention of coronary disease.
    Fuster V; Cohen M; Halperin J
    N Engl J Med; 1989 Jul; 321(3):183-5. PubMed ID: 2747748
    [No Abstract]   [Full Text] [Related]  

  • 18. [Platelet antiaggregants and coronary pathology].
    Castaigne A; Duval-Moulin AM; Dutoit C
    Rev Prat; 1989 Nov; 39(25):2228-33. PubMed ID: 2688043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin in the prevention of catastrophes of the coronary circulation.
    Oates JA
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():57-63. PubMed ID: 2526539
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M
    Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.